Skip to main content
Pathway Health Corp. logo

Pathway Health Corp. — Investor Relations & Filings

ISIN · CA70324L1058 LEI · 984500AB5C0A5E0D4392 TSXV Human health and social work activities
Open in API
Filings indexed 203 across all filing types
Latest filing 2023-07-28 Board/Management Inform…
Country CA Canada
Listing TSXV

About Pathway Health Corp.

https://pathwayhealth.ca/

Pathway Health Corp. is a healthcare organization specializing in the provision of out-of-hospital pain management services. The company operates a network of community-based clinics that deliver multi-disciplinary therapies and medically managed intensive outpatient programs. Its primary focus is assisting patients suffering from chronic pain, with an expanded scope now addressing mental illness following a corporate combination with other health and wellness firms. Beyond clinical operations, Pathway Health also functions as a professional management and consulting organization, offering strategic technology implementation and education solutions across the healthcare continuum. This dual focus positions the company as a comprehensive provider of specialized health services.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing the resignation of the entire management team and board of directors of Pathway Health Corp. It details the resignations of specific executives and directors and mentions the company's inability to secure financing and maintain operations. There is no financial data, no report attached or referenced as being published, and no mention of voting results or other regulatory filings. The content is clearly about changes in the company's board and senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, supporting this classification with high confidence.
2023-07-28 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing an update on a proposed arrangement (a plan of arrangement transaction) that was denied court approval, and a short-term forbearance on repayment of secured indebtedness. It discusses the failure of a merger/acquisition transaction, the company's strategic alternatives including potential sale, shutdown, or merger, and a forbearance agreement on a convertible promissory note. There are no financial statements or detailed financial data presented, nor is this a transcript, annual or quarterly report, or governance document. The content focuses on a transaction update and financing forbearance, which fits best under Capital/Financing Update (CAP). The document is about financing and transaction status, not a full merger filing or proxy statement, so it is not MA or PSI. It is not a regulatory filing or announcement of a report publication. Therefore, the best classification is Capital/Financing Update (CAP).
2023-07-12 English
News release - English.pdf
Regulatory Filings
2023-06-27 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the voting results from the 2023 Annual and Special Meeting of Pathway Health Corp. It includes election of directors, appointment of auditors, approval of share option plans, and other shareholder resolutions. The content focuses on the outcomes of shareholder votes rather than presenting financial statements or management discussion. The document is not a full annual report, interim report, or earnings release. It is not a proxy solicitation or a report publication announcement. The presence of detailed voting results and shareholder resolutions clearly identifies this as a Declaration of Voting Results & Voting Rights Announcements filing.
2023-06-01 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed financial report for the first quarter of 2023, including comprehensive financial results, management discussion and analysis (MD&A), and interim condensed consolidated financial statements. It covers revenues, expenses, EBITDA, adjusted EBITDA, and other financial metrics for the three months ended March 31, 2023, compared to the prior year. The document also discusses a significant plan of arrangement (merger/acquisition) and financing activities but primarily focuses on quarterly financial performance. The length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-05-31 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2023-05-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.